6/8/2023 | BK | AngioDynamics to repay existing debt via proceeds from product sales
|
8/31/2022 | BK | AngioDynamics signs for $75 million revolver, $30 million term loan
|
4/7/2020 | BK | AngioDynamics focuses on cash position, draws $25 million on revolver
|
1/16/2020 | BK | AngioDynamics has strong balance sheet, access to lenders if needed
|
7/10/2019 | BK | AngioDynamics pays off all debt, gets $125 million credit agreement
|
6/6/2019 | BK | AngioDynamics repays credit facility, gets new $125 million revolver
|
1/4/2019 | BK | AngioDynamics could take leverage above 3x for the right acquisition
|
7/11/2018 | BKBW | AngioDynamics sees better balance sheet, ‘consistent’ free cash flow
|
1/6/2017 | BK | AngioDynamics to pay down credit facility voluntarily from cash flow
|
11/10/2016 | BK | AngioDynamics closes $100 million term loan, $150 million revolver
|
7/13/2016 | BK | AngioDynamics ends Q4 with $34 million cash, debt of $121.4 million
|
9/24/2013 | BK | AngioDynamics gets $200 million five-year loan, revolver; pricing cut
|
2/7/2012 | BK | AngioDynamics expects $150 million loan spread at Libor plus 250 bps
|
1/31/2012 | BK | AngioDynamics plans $200 million credit facility with Navilyst buy
|
5/13/2009 | SS | Market Commentary: Agency OKs expected on Frontier buy; Alpha forecast to pass reviews; VNUS on track to close
|
1/29/2007 | SS | AngioDynamics, RITA complete merger
|
1/25/2007 | SS | AngioDynamics, RITA merger closing expected on Jan. 29
|
10/18/2006 | BT | AngioDynamics rated outperform by RBC
|
10/11/2006 | BT | AngioDynamics has sufficient liquidity for next 12 months
|
10/10/2006 | BT | AngioDynamics kept at outperform by RBC
|
9/25/2006 | BT | RBC keeps AngioDynamics at outperform
|
9/11/2006 | BT | Diomed prevails in sheath patent litigation, AngioDynamics' claims denied
|
8/31/2006 | BT | Market Commentary: Genta off 15.5%; EpiCept off on PIPE; AnorMED steady; Diomed gains 28%; ImmunoGen higher
|
8/25/2006 | BT | RBC maintains AngioDynamics at outperform
|
8/11/2006 | BT | AngioDynamics kept at outperform by RBC
|
8/2/2006 | BT | AngioDynamics maintained at outperform by RBC
|
7/13/2006 | BT | AngioDynamics to become Bioniche Pharma's exclusive U.S. distributor of Sotradecol for sclerotherapy
|
6/26/2006 | BT | Judge recuses himself from Diomed case after treatment by expert witness
|
5/24/2006 | BT | Market Commentary: Sirna, Minrad, AngioDynamics follow-on deals get off; bird flu vaccine names continue to climb
|
5/24/2006 | BT | New Issue: AngioDynamics raises $57.8 million in follow-on of 2.4 million shares at $24.07 each
|
5/3/2006 | BT | Market Commentary: MGI, SuperGen get nod from FDA for Dacogen; Impax stock climbs on FDA OK of generic Colestid
|
5/2/2006 | BT | AngioDynamics to sell 2.4 million shares
|
3/21/2006 | BT | AngioDynamics ups guidance after record sales increase third-quarter net income by 73%
|
11/30/2005 | BT | AngioDynamics obtains $7.5 million revolver
|